Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7464 p143
11 August 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Contractors could miss out on benefits of EPS release 2 if online data are not up to date

Sinan Isakovic/Dreamstime.com

Pharmacists may need to update information on nhs.uk

Pharmacists may need to update information on nhs.uk

Pharmacy contractors must ensure that information held on the NHS choices website is up to date or they risk being disadvantaged when Release 2 of the Electronic Prescription Service (EPS) starts later this year (2007).

The Pharmaceutical Services Negotiating Committee is advising contractors to check now whether the information is correct, in particular that the pharmacy name displayed is the pharmacy’s current trading name.

Release 2 of the EPS will allow patients to nominate the pharmacy at which they would routinely like their prescriptions dispensed. They will be able to do so at any GP surgery or pharmacy, and eventually, online on the NHS Healthspace website.

Information on Release 2-enabled pharmacies will be provided by nhs.uk, which will automatically be updated by the Prescription Pricing Division when pharmacies become enabled. It is, therefore, important that information is up to date so that prescribers can locate and nominate a particular pharmacy on their prescribing system.

Contractors wishing to amend their nhs.uk entry — including changing the name, address, telephone number, opening hours or the services provided — should make a written request via their primary care trust.

NHS Connecting for Health and the PSNC will be issuing guidance on the nomination function and on collecting patient consent for nomination shortly.

Ben Bradshaw Ben Bradshaw has been named as the new minister for state in charge of the NHS IT programme. He takes over responsibility for NHS Connecting for Health and the National Programme for IT from Lord Hunt, who has moved to the Ministry of Justice.

Back to Top


©The Pharmaceutical Journal